← back to search

Albert Rosenberger

Klinikum Konstanz · DE
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Genetic Associations and Epidemiology, Cutaneous Melanoma Detection and Management, Lung Cancer Treatments and Mutations, and RNA modifications and cancer.
h-index
43
citations
8,063
works
202
NIH funding
primary concept
Medicine
email

Recent publications

Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
Annals of Oncology 2020cited by 227position: middledoi
Protein-altering germline mutations implicate novel genes related to lung cancer development
Nature Communications 2020cited by 47position: middledoi
Skin lesions of face and scalp – Classification by a market-approved convolutional neural network in comparison with 64 dermatologists
European Journal of Cancer 2020cited by 43position: middledoi
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk
Nature Communications 2018cited by 80position: middledoi
Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners
International Archives of Occupational and Environmental Health 2018cited by 37position: firstdoi
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
Nature Genetics 2017cited by 786position: middledoi
Pathway‐analysis of published genome‐wide association studies of lung cancer: A potential role for the <i>CYP4F3</i> locus
Molecular Carcinogenesis 2017cited by 20position: middledoi
Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis
EBioMedicine 2016cited by 44position: middledoi
CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis—A Meta-Analysis
JNCI Journal of the National Cancer Institute 2015cited by 76position: middledoi
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
Human Molecular Genetics 2015cited by 23position: middledoi
META-GSA: Combining Findings from Gene-Set Analyses across Several Genome-Wide Association Studies
PLoS ONE 2015cited by 5position: firstdoi
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
Nature Genetics 2014cited by 481position: middledoi
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls
Human Genetics 2013cited by 36position: middledoi
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls
Human Molecular Genetics 2012cited by 240position: middledoi
Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium
American Journal of Epidemiology 2012cited by 213position: middledoi
Informed Conditioning on Clinical Covariates Increases Power in Case-Control Association Studies
PLoS Genetics 2012cited by 98position: middledoi
Increased Genetic Vulnerability to Smoking at CHRNA5 in Early-Onset Smokers
Archives of General Psychiatry 2012cited by 77position: middledoi
PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells
PLoS ONE 2012cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Angela Risch · German Cancer Research Center4 papers (2013–2017)Christopher I. Amos · UNM Comprehensive Cancer Center4 papers (2013–2017)Joachim Heinrich · Monash University4 papers (2013–2017)Heike Bickeböller · National Center for Tumor Diseases3 papers (2013–2015)John McLaughlin · McGill University Health Centre3 papers (2013–2017)Gordon Fehringer · NewYork–Presbyterian Hospital2 papers (2015–2015)Thomas Muley · Heidelberg University2 papers (2013–2015)Younghun Han · Dae Hwa Pharm (South Korea)2 papers (2015–2017)Yonathan Brhane · National Center for Tumor Diseases2 papers (2015–2017)Darren R. Brenner · University of Calgary1 papers (2013–2013)Kouros Owzar · Duke University1 papers (2017–2017)John K. Field · University of Liverpool1 papers (2015–2015)John S. Witte · Stanford University1 papers (2013–2013)Martina Müller‐Nurasyid · Johannes Gutenberg University Mainz1 papers (2015–2015)Fredrick R. Schumacher · Case Western Reserve University1 papers (2015–2015) · 1 papers (2012–2012)Juan Pablo Lewinger · UPMC Hillman Cancer Center1 papers (2013–2013) · 1 papers (2012–2012)Jyoti Malhotra · City Of Hope National Medical Center1 papers (2015–2015)Douglas F. Easton · Pacific Biomarkers (United States)1 papers (2015–2015)